Corteva VP Titus sells $636,199 in CTVA stock
#Corteva #Insider Trading #Stock Sale #CTVA #Brian Titus #Market Analysis #Business Separation #Earnings Report
📌 Key Takeaways
- Brian Titus sold $636,199 worth of Corteva stock on February 20, 2026
- The stock is trading near its 52-week high, having gained 25% over the past year
- Corteva's Q4 2025 earnings met EPS expectations but revenue fell short
- Analysts have downgraded Corteva's stock rating due to strategic business separation plans
📖 Full Retelling
Brian Titus, Corteva's VP, Controller and Principal Accounting Officer, sold $636,199 worth of company stock on February 20, 2026, as disclosed in a Form 4 filing with the Securities and Exchange Commission. The transactions involved the sale of 8,311 shares of Corteva, Inc. common stock executed at prices ranging from $76.5318 to $76.5652 per share. Additionally, Titus exercised options to acquire 4,311 shares at $50.70 per share, totaling $218,567, and disposed of 132 shares at $76.31 to cover taxes on vested restricted stock units. Following these transactions, Titus directly owns approximately 8,090 shares of Corteva stock. The timing of the sale is noteworthy as CTVA stock is trading near its 52-week high of $77.98, having delivered a 25% return over the past year, though InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value. This comes amid recent financial news where Corteva's fourth-quarter 2025 earnings per share met expectations at $0.22, but revenue fell short at $3.91 billion versus the anticipated $4.24 billion. The company is also planning to separate its Seed and Crop Chemicals businesses later in 2026, a strategic move that has prompted analyst downgrades from both UBS and JPMorgan, who have adjusted their ratings to Neutral amid concerns about execution risks and potential dissynergies.
🏷️ Themes
Insider Trading, Corporate Finance, Market Analysis, Strategic Restructuring
📚 Related People & Topics
Insider trading
Trading using nonpublic information
# Insider Trading **Insider trading** is the trading of a public company's stock or other securities (such as bonds or stock options) based on **material, nonpublic information** about the company. While the practice is common, its legality is subject to complex regulations that vary significantly ...
Corteva
American agriculture company
Corteva, Inc. (also known as Corteva Agriscience) is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals (natural herbicides) that are sold in 110 countries. The company's name combines "cor" (Latin for "heart") with...
Entity Intersection Graph
Connections for Insider trading:
🌐
SEC filing
5 shared
👤
New York Stock Exchange
4 shared
👤
Rachel Haurwitz
3 shared
🌐
ZWS
2 shared
🌐
Biopharmaceutical
2 shared
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry AMD stock surges 14% on Meta AI partnership deal Bitcoin slips, wipes out 50% from October record high at session low Wall Street ends higher on tech rebound ahead of State of the Union address Software stocks rebound as Anthropic partnerships ease AI disruption fears (South Africa Philippines Nigeria) Corteva VP Titus sells $636,199 in CTVA stock By Investing.com Insider Trading Published 02/24/2026, 11:17 PM Corteva VP Titus sells $636,199 in CTVA stock 0 CTVA 1.97% Corteva NASDAQ:CTVA VP, Controller and Principal Accounting Officer Brian Titus, sold 8,311 shares of Corteva, Inc. common stock on February 20, 2026, for a total of $636,199. The sales were executed in multiple transactions at prices ranging from $76.5318 to $76.5652. The timing of the sale is notable as the stock is trading near its 52-week high of $77.98, having delivered a 25% return over the past year. According to a Form 4 filing with the Securities and Exchange Commission, Titus also exercised options to acquire 4,311 shares of Corteva common stock at a price of $50.70 per share, for a total value of $218,567. Additionally, 132 shares were disposed of at a price of $76.31, for a total value of $10072. These shares were withheld by Corteva to cover taxes due following the vesting of previously granted restricted stock units. Following these transactions, Titus directly owns 8089.9918 shares of Corteva, Inc. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value. Investors seeking deeper insights can access a comprehensive Pro Research Report on Corteva, one of 1,400+ available reports transforming complex data into actionable intelligence. In other recent news, Corteva Agriscience reported its fourth-quarter 2025 earnings, with earnings per share meeting expectations at $0.22. However, revenue fell short of forecasts, coming in at $3.91 billion compared to the anticipated $4.24 billion. This e...
Read full article at source